A causal role of coronary thrombosis in evolving myocardial infarction is now widely accepted. Patients recovering from an acute heart attack have a higher risk of dying, or suffering another infarction, than an age-matched noncoronary population. Thrombosis plays a major part in this additional mortality and morbidity. The use of oral anticoagulants in the secondary prophylaxis of acute myocardial infarction is controversial. This article reviews the role of oral anticoagulant drugs in the prevention of secondary events in patients who have survived a heart attack.
|Number of pages||5|
|Journal||Archives of Pathology and Laboratory Medicine|
|State||Published - 1993|